Aneuclose: The Team
The Aneuclose LLC management,
research, and investment team includes:
Tariq Janjua M.D.:
Dr. Janjua is a Neurointensivist with experience as the Medical Director
of a Neurocritical Care Medicine unit. Dr. Janjua is one of less
than than 100 physicians who have become board-certified in Neurocritical
Care. He is also board-certified in Internal Medicine and Critical
Care Medicine. Journals in which Dr. Janjua has published include
the Journal of Neurosurgery, the Journal of Clinical Neuroscience, and
Robert Connor, Ph.D.:
Professor Connor, a graduate of Princeton, Duke, and the Wharton School
of the University of Pennsylvania, is a serial entrepreneur and inventor.
Professor Connor has taught courses and conducted research in the health
sector for over twenty years, including courses on product development
(including prototyping) and medical technology (including assessing unmet
clinical need and market potential). Dr. Connor also served on the
Health Care Technology Decision Sciences Study Section of the Agency for
Healthcare Research and Quality and has been the Principal Investigator
on competitive federally-funded research projects.
Peter DeLange, M.B.A.:
Mr. Delange is the CEO of Devicix, a leading contract medical device engineering
and product development firm in Minnesota that provides research and commercial
development services to established and early-stage medical devices companies,
as well as to physicians and researchers seeking to bring their own ideas
to market. Devicix focuses exclusively on the medical device industry.
The professionals at Devicix include biomedical, mechanical, electrical,
software and quality engineers with B.S., M.S. and Ph.D. degrees.
Mark Knudson, Ph.D.:
Dr. Knudson has extensive executive experience in the medical technology
sector and served as a partner of an early stage venture capital firm.
Dr. Knudson received the Ph.D. degree in physiology from Washington State
University and a B.S. degree in biology from Pacific Lutheran University.
He holds numerous United States patents.